Ecstasy Helps Treat PTSD Patients, Trial Finds
Campaign posters supporting Egyptian presidential candidate Ahmed Shafiq, the last prime minister of deposed president Hosni Mubarak, hang above a popular market in Cairo, Egypt, Tuesday, June 12, 2012. Arabic on the banners reads: "Ahmed Shafiq for Egyptian presidency", and "Egypt for all."(AP Photo/Amr Nabil) / Amr Nabil
People suffering from the agony of post-traumatic stress disorder (PTSD) may one day find relief with Ecstasy.
A small clinical trial found that 80 percent of participants treated with a combination of methylenedioxymethamphetamine (MDMA) and psychotherapy no longer showed signs of PTSD, with no serious side effects.
Three people who also said the disorder prevented them from going to work were able to return to their jobs after the treatment.
The study is the first completed clinical trial evaluating MDMA as a therapeutic adjunct since it was criminalized in 1985 owing to recreational use of the drug, known by its street name Ecstasy.
Twenty patients who had suffered with chronic PTSD for an average of more than 19 years and who had not obtained relief from both psychotherapy and psychopharmacology were randomly assigned to two eight-hour psychotherapy sessions, with 12 subjects receiving the drug and eight receiving a placebo.
Both groups also received psychotherapy before and after the drugs were administered. Follow-ups were conducted four days and two months after each day-long session.
At all recorded times after baseline, a decrease in Clinician-Administered PTSD Scale scores was significantly greater for the group that received MDMA than for the placebo group.
The rate of clinical response, according to diagnostic criteria for PTSD as stipulated in the DSM-IV-TR, was 83 percent in the active treatment group, versus 25 percent in the placebo group.
Investigators did detect raised blood pressure and other symptoms in the MDMA group. But there were no drug-related serious adverse events, adverse neurocognitive effects, or clinically significant blood pressure or temperature increases.
A long-term follow-up evaluating the same subjects is underway.
The authors did state that most participants accurately guessed whether they were receiving MDMA or the placebo, which has no psychoactive effect. The trials also did not look at gender or ethnic factors in their sample selection.
The study's authors also admit that the two all-day therapy sessions and overnight stays at the clinic are not usual features of outpatient psychotherapy. But they believe that MDMA-assisted psychotherapy can be administered to PTSD patients without evidence of harm, who have been resistant to other treatments.
The study, published today in the Journal of Psychopharmacology, was sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) which, through its MDMA Psychotherapy Research Fund, hopes to develop MDMA into an FDA-approved prescription medication for therapeutic use in conjunction with PTSD.
The trials were led by MAPS' President Rick Doblin, Ph.D., South Carolina-based psychiatrist Dr. Michael Mithoefer, and colleagues with the Medical University of South Carolina in Charleston.
Copyright 2010 CBS. All rights reserved. A small clinical trial found that 80 percent of participants treated with a combination of methylenedioxymethamphetamine (MDMA) and psychotherapy no longer showed signs of PTSD, with no serious side effects.
Three people who also said the disorder prevented them from going to work were able to return to their jobs after the treatment.
The study is the first completed clinical trial evaluating MDMA as a therapeutic adjunct since it was criminalized in 1985 owing to recreational use of the drug, known by its street name Ecstasy.
Twenty patients who had suffered with chronic PTSD for an average of more than 19 years and who had not obtained relief from both psychotherapy and psychopharmacology were randomly assigned to two eight-hour psychotherapy sessions, with 12 subjects receiving the drug and eight receiving a placebo.
Both groups also received psychotherapy before and after the drugs were administered. Follow-ups were conducted four days and two months after each day-long session.
At all recorded times after baseline, a decrease in Clinician-Administered PTSD Scale scores was significantly greater for the group that received MDMA than for the placebo group.
The rate of clinical response, according to diagnostic criteria for PTSD as stipulated in the DSM-IV-TR, was 83 percent in the active treatment group, versus 25 percent in the placebo group.
Investigators did detect raised blood pressure and other symptoms in the MDMA group. But there were no drug-related serious adverse events, adverse neurocognitive effects, or clinically significant blood pressure or temperature increases.
A long-term follow-up evaluating the same subjects is underway.
The authors did state that most participants accurately guessed whether they were receiving MDMA or the placebo, which has no psychoactive effect. The trials also did not look at gender or ethnic factors in their sample selection.
The study's authors also admit that the two all-day therapy sessions and overnight stays at the clinic are not usual features of outpatient psychotherapy. But they believe that MDMA-assisted psychotherapy can be administered to PTSD patients without evidence of harm, who have been resistant to other treatments.
The study, published today in the Journal of Psychopharmacology, was sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) which, through its MDMA Psychotherapy Research Fund, hopes to develop MDMA into an FDA-approved prescription medication for therapeutic use in conjunction with PTSD.
The trials were led by MAPS' President Rick Doblin, Ph.D., South Carolina-based psychiatrist Dr. Michael Mithoefer, and colleagues with the Medical University of South Carolina in Charleston.
Popular in Health
- Feet come first when it comes to body parts with most fungi
- Mysterious respiratory disease infects 7 in Ala., 2 dead
- Airway made by 3D printer saves infant's life
- Almost all states seeing big drop in teen birth rates
- Skin cancer self-exam: What to look for (PHOTOS)
- "Clouds" singer known for viral hit dies from osteosarcoma
- Surgeons remove 4-pound hairball from tiger 10 Photos
- Heartburn raises throat cancer risk but antacids may help
well ... the placebo will do exactly the same thing as the real drug when it behaves like a placebo. in fact ... they've now found that drugs like prozac ... and others that have been around for a while ... actually exhibit a much higher placebo effect 20 years later ... than what was measured when the drug was first studied (for it's initial approval).
the understanding of placebo effect is still in it's infancy.
Why not this drug as well? I think some day the psychedelics will finally get the respect they deserve.
so do oncologists (cancer) ... cardiologists (heart) ... and endocrinologists (diabetes).
This is the natural next step in psychiatry. They have long been nothing more than licensed drug peddlers more intent on enslaving the person with drugs and grabbing their cash than they care about actually curing a person.
The psychotherapy is a meaningless exercise better viewed as a walletectomy so you are no better off with this "therapy" than you are visiting the drug dealer down on the corner.
Nothing changes except for when it gets worse.
------------
You clearly have never experienced PTSD. I have. I also know quite a bit about psychiatry and therapy. You clearly don't. You have no right to disparage a whole profession. I know what has helped me, and what hasn't. You don't. Don't pretend you know what you are talking about. Try walking in my shoes just a little bit. Ask questions. Learn about the disorder.
so who exactly defines the threshold that clearly describes what 'insanse' is?
isn't it really just shades of grey ... or are you a 'black/white' type of guy?
The psychotherapy is a meaningless exercise better viewed as a walletectomy so you are no better off with this "therapy" than you are visiting the drug dealer down on the corner.
Nothing changes except for when it gets worse.
your view can be best characterized by the old phrase 'throwing the baby out with the bathwater'. nothing has the same effect for everyone ... but to say that these things don't help anyone is presumptuous.
your whole brain is one big chemical and electrical system. mind manifests from the brain and central nervous system. these conditions are effectively 'chemical/electrical' imbalances of that system. these drugs target those imbalances. in some cases the drugs are not required indefinitely to correct a condition.